Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth–Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Solid tumors possess a unique internal environment with high‐level thiols (mainly glutathione), over‐expressed H 2 O 2, and low oxygen partial pressure, which severely restrict the radiotherapy (RT) efficacy. To overcome the imperfections of RT alone, there is vital to design a multifunctional radiosensitizer that simultaneously achieves multimodal therapy and tumor microenvironment (TME) regulation. Bismuth (Bi)‐based nanospheres are wrapped in the MnO 2 layer to form core–shell‐structured radiosensitizer (Bi@Mn) that can effectively load docetaxel (DTX). The solubility of Bi@Mn‐DTX is further improved via folic acid‐modified amphiphilic polyethylene glycol (PFA). Bi@Mn‐DTX‐PFA can specifically respond to the TME to realize multimodal therapy. Primarily, the outer MnO 2 layer responds with H 2 O 2 and glutathione to release oxygen and generate •OH, thereby alleviating hypoxia and achieving chemodynamic therapy (CDT). Afterward, the strong coordination between Bi 3+ and deprotonated thiol groups in glutathione allows the mesoporous Bi‐containing core bonding with glutathione to form a water‐soluble complex. These actions conduce Bi@Mn‐DTX‐PFA degradation, further releasing DTX to implement chemotherapy (CHT). In addition, the degradation in vivo and tumor enrichment of Bi@Mn‐PFA are explored via T 1‐weighted magnetic resonance and computed tomography imaging. The biodegradable composite Bi@Mn‐DTX‐PFA can simultaneously modulate the TME and achieve multimodal treatment (RT/CDT/CHT) for hypoxic tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
Li, X., Yang, X., Lin, Z., Wang, D., Mei, D., He, B., Wang, X., Wang, X., Zhang, Q., & Gao, W. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.04.018 · Cited by 56
Self-citation
Cited by
Recent Developments of Inorganic Nanosensitizers for Sonodynamic Therapy
He, Z., Du, J., Miao, Y., & Li, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300234 · Cited by 105
Self-citationColak, B., & Ertas, Y. N. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17024 · Cited by 50
Research progress on nano-sensitizers for enhancing the effects of radiotherapy
Zhang, Y., Han, X., Liu, Y., Wang, S., Han, X., & Cheng, C. (2022) · Materials Advances · doi:10.1039/d2ma00094f · Cited by 44
Dastgir, M., Ayyami, Y., Ghorbani, M., Yektamanesh, M., Ghasemi Jangjoo, A., Zamani, H., Jazzi, S. S., Mehrizi, O. A., Mortezazadeh, T., & Malekzadeh, R. (2026) · Cancer Nanotechnology · doi:10.1186/s12645-025-00359-6 · Cited by 4
Metadata
- Authors
- Liu, J., Zhang, J., Song, K., Du, J., Wang, X., Liu, J., Li, B., Ouyang, R., Miao, Y., Sun, Y., & Li, Y.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2021-07-15
- Volume
- 17
- Issue
- 34
- Pages
- e2101015-e2101015
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W3182940592
- Cited by
- 75
- References
- 3
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth–Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors. https://app.cochat.ai/papers/10.1002/smll.202101015
- The paper
- Liu, J., Zhang, J., Song, K., Du, J., Wang, X., Liu, J., Li, B., Ouyang, R., Miao, Y., Sun, Y., & Li, Y. (2021). Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth–Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors. Small. https://doi.org/10.1002/smll.202101015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.